![White car (Porsche Taycan) with the hood popped is inside the building with an american flag on the wall.](/sites/default/files/styles/featured_square_large/public/2024-06/2024-P09317.jpg?h=8f9cfe54&itok=m6sQhZRq)
Filter News
Area of Research
- Advanced Manufacturing (1)
- Biology and Environment (11)
- Clean Energy (13)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (13)
- Fusion Energy (1)
- Isotopes (4)
- Materials (3)
- Mathematics (1)
- National Security (1)
- Neutron Science (5)
- Nuclear Science and Technology (1)
- Sensors and Controls (1)
- Supercomputing (4)
News Topics
- (-) Advanced Reactors (2)
- (-) Artificial Intelligence (7)
- (-) Biomedical (10)
- (-) Clean Water (8)
- (-) Fusion (8)
- (-) Grid (11)
- (-) ITER (4)
- (-) Nuclear Energy (6)
- (-) Security (3)
- (-) Space Exploration (4)
- 3-D Printing/Advanced Manufacturing (26)
- Big Data (5)
- Bioenergy (13)
- Biology (23)
- Biotechnology (5)
- Buildings (13)
- Chemical Sciences (7)
- Climate Change (11)
- Composites (6)
- Computer Science (30)
- Coronavirus (10)
- Critical Materials (4)
- Cybersecurity (5)
- Decarbonization (7)
- Energy Storage (22)
- Environment (39)
- Exascale Computing (2)
- Frontier (4)
- High-Performance Computing (19)
- Isotopes (12)
- Machine Learning (1)
- Materials (32)
- Materials Science (22)
- Mathematics (1)
- Mercury (3)
- Microscopy (10)
- Nanotechnology (10)
- National Security (7)
- Net Zero (1)
- Neutron Science (18)
- Physics (3)
- Polymers (5)
- Quantum Computing (5)
- Quantum Science (12)
- Statistics (1)
- Summit (9)
- Sustainable Energy (35)
- Transportation (21)
Media Contacts
![Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/Deborah%20Frincke%20profile_0.jpg?h=8caed45b&itok=0eTC4gMH)
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
![Vittorio Badalassi, left, of Oak Ridge National Laboratory leads the Fusion Energy Reactor Models Integrator, or FERMI, project, and collaborates with ORNL computational physicist David Green. FERMI applies fission platforms to fusion reactor design. Credit: Commonwealth Fusion Systems and Colby Earles/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/FERMI_v3_web_art_for_landing_page_carousel_2021_04_20_1.jpg?h=d1cb525d&itok=y2KEq11p)
Oak Ridge National Laboratory expertise in fission and fusion has come together to form a new collaboration, the Fusion Energy Reactor Models Integrator, or FERMI
![ORNL’s Sergei Kalinin and Rama Vasudevan (foreground) use scanning probe microscopy to study bulk ferroelectricity and surface electrochemistry -- and generate a lot of data. Credit: Jason Richards/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/KalininVasudevan_2017-P03014_0.jpg?h=1116cd87&itok=KEEOB4hi)
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Oak Ridge National Laboratory’s MENNDL AI software system can design thousands of neural networks in a matter of hours. One example uses a driving simulator to evaluate a network’s ability to perceive objects under various lighting conditions. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/CARLA%20MENNDL%20sim001_1.png?h=e2caa22a&itok=tvE9seMo)
The Department of Energy’s Oak Ridge National Laboratory has licensed its award-winning artificial intelligence software system, the Multinode Evolutionary Neural Networks for Deep Learning, to General Motors for use in vehicle technology and design.
![Nuclear engineer Nesrin Ozgan Cetiner led ORNL’s collaboration with AMS Corp. to test instrument and control sensors for the next generation of nuclear power reactor technology. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/Nesrin_Cetiner_AMS_article_2021-P02224%5B2%5D.jpg?h=acaf5000&itok=YDUKbigy)
Toward the goal of bringing the next generation of nuclear power reactor technology online this decade, ORNL and Analysis and Measurement Services Corporation have successfully completed loop testing of instrument and control sensors for an advanced reactor design for small modular reactors.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/gif_high_res.gif?h=ae1281eb&itok=QtNBjm3O)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/after_transprent_background-wFill.png?h=c71d0c67&itok=jGFt_Ggj)
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.